NasdaqGM - Nasdaq Real Time Price USD

Immutep Limited (IMMP)

2.6700 -0.1800 (-6.32%)
At close: June 7 at 4:00 PM EDT
Currency in AUD All numbers in thousands
Download
Breakdown
TTM
6/30/2023
6/30/2022
6/30/2021
6/30/2020
6/30/2019
Total Revenue
--
--
170.3690
--
7,486.4440
--
Operating Expense
--
41,431.3050
34,007.7070
19,656.0790
22,558.4610
--
Operating Income
--
-41,431.3050
-33,837.3380
-19,656.0790
-15,072.0170
--
Net Non Operating Interest Income Expense
--
918.5980
132.0900
95.5020
189.0840
--
Other Income Expense
--
616.3590
1,494.4560
-10,342.0140
1,414.7380
--
Pretax Income
--
-39,896.3480
-32,210.7920
-29,902.5910
-13,468.1950
--
Tax Provision
--
--
0.0340
0.0330
0.0370
--
Net Income Common Stockholders
--
-39,896.3480
-32,210.8260
-29,902.6240
-13,468.2320
--
Diluted NI Available to Com Stockholders
--
-39,896.3480
-32,210.8260
-29,902.6240
-13,468.2320
--
Basic EPS
-0.39
-0.45
-0.38
-0.50
-0.32
--
Diluted EPS
-0.39
-0.45
-0.38
-0.50
-0.32
--
Basic Average Shares
118,883.4560
89,239.9810
84,896.8070
59,492.7440
41,935.7630
--
Diluted Average Shares
118,883.4560
89,239.9810
84,896.8070
59,492.7440
41,935.7630
--
Total Expenses
--
41,431.3050
34,007.7070
19,656.0790
22,558.4610
--
Net Income from Continuing & Discontinued Operation
--
-39,896.3480
-32,210.8260
-29,902.6240
-13,468.2320
--
Normalized Income
--
-40,651.7550
-33,484.2604
-23,483.5855
-15,261.0328
--
Interest Income
--
938.9990
224.5200
105.3270
199.5410
--
Interest Expense
--
20.4010
92.4300
9.8250
10.4570
--
Net Interest Income
--
918.5980
132.0900
95.5020
189.0840
--
EBIT
--
-39,875.9470
-32,118.3620
-29,892.7660
-13,457.7380
--
EBITDA
--
-39,875.9470
-32,118.3620
-29,892.7660
-13,457.7380
--
Reconciled Depreciation
--
--
2,999.6134
--
2,079.6390
1,879.1510
Net Income from Continuing Operation Net Minority Interest
--
-39,896.3480
-32,210.8260
-29,902.6240
-13,468.2320
--
Total Unusual Items Excluding Goodwill
755.4070
755.4070
1,819.1920
-9,170.0550
2,561.1440
--
Total Unusual Items
755.4070
755.4070
1,819.1920
-9,170.0550
2,561.1440
--
Normalized EBITDA
--
-40,631.3540
-33,937.5540
-20,722.7110
-16,018.8820
--
Tax Rate for Calcs
--
--
0.0003
0.0003
0.0003
--
Tax Effect of Unusual Items
--
--
545.7576
-2,751.0165
768.3432
--
6/30/2019 - 4/19/2012

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

MESO Mesoblast Limited
7.14
+4.69%
 
SLS SELLAS Life Sciences Group, Inc.
1.4500
-1.36%
 
RCUS Arcus Biosciences, Inc.
15.50
-2.52%
 
ZLAB Zai Lab Limited
20.00
+5.26%
 
GLYC GlycoMimetics, Inc.
0.2574
-1.11%
 
SPRB Spruce Biosciences, Inc.
0.6770
+0.45%
 
EQ Equillium, Inc.
0.8010
-10.69%
 
MDNAF Medicenna Therapeutics Corp.
1.7500
+1.16%
 
VTYX Ventyx Biosciences, Inc.
3.2600
-0.76%
 
SGMT Sagimet Biosciences Inc.
4.7000
+1.08%